Moderna has said it is filing for regulatory approval in the US, and that its vaccine trials have shown no serious safety concerns.

The US-based company has also said its vaccine was 94.1% effective, with 100% efficacy against severe COVID-19 in its phase three trial.

Efficacy was consistent across age, race and ethnicity, as well as gender, the company has said.

Speaking to Reuters news agency, chief medical officer Dr Tal Zaks said: “We believe that we have a vaccine that is very highly efficacious. We now have the data to prove it.”

You May Also Like

Biden becomes first US president to commemorate Tulsa race massacre as he visits site

Joe Biden has become the first sitting US president to visit the…

Rust crew deny film set was ‘chaotic and dangerous’ after Alec Baldwin prop gun shooting

Claims that the Rust film set was a “chaotic, dangerous and exploitative”…

Manhunt ongoing as eight-year-old boy among five killed in Texas neighbour shooting

Five members of a family including an eight-year-old boy have been killed…

Titan sub investigators ‘taking precautions’ in case bodies found on sea floor

The US Coast Guard has said investigators looking into the Titan submersible implosion…